Supply chain visibility remains a key initiative for many businesses, but visibility requires a partnership with suppliers and other partners within the supply chain. How do you optimize that ...
Radiopharmaceuticals are a promising new class of drugs generating lots of excitement for pharmaceutical companies. However, their shorter shelf life means they have differences in manufacturing to ...
The complexity of third-party external supply networks requires new ways to manage them. I had dinner recently with an old and very insightful Big Pharma colleague of mine and after speaking together, ...